These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 12131232)
1. Scientific considerations for the regulation and clinical evaluation of HIV/AIDS preventive vaccines: report from a WHO-UNAIDS Consultation 13-15 March 2001, Geneva, Switzerland. AIDS; 2002 Jul; 16(10):W15-25. PubMed ID: 12131232 [TBL] [Abstract][Full Text] [Related]
2. Executive summary and recommendations from WHO/UNAIDS and AAVP consultation on: 'The inclusion of adolescents in HIV vaccine trials', 16-18 March 2006 in Gaborone, Botswana. ; Osmanov S AIDS; 2007 Sep; 21(14):W1-10. PubMed ID: 17721089 [TBL] [Abstract][Full Text] [Related]
3. AIDS vaccine research in Asia: needs and opportunities. Report from a UNAIDS/WHO/NIID meeting Tokyo, 28-30 October 1998. AIDS; 1999 Jul; 13(11):UNAIDS 1-UNAIDS 13. PubMed ID: 10449273 [TBL] [Abstract][Full Text] [Related]
4. Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USA. WHO/UNAIDS/IAVI International Expert Group AIDS; 2007 Feb; 21(4):539-46. PubMed ID: 17301582 [TBL] [Abstract][Full Text] [Related]
5. Future access to HIV vaccines. Report from a WHO-UNAIDS Consultation, Geneva, 2-3 October 2000. AIDS; 2001 May; 15(7):W27-44. PubMed ID: 11399975 [TBL] [Abstract][Full Text] [Related]
6. Public health considerations for the use of a first generation HIV vaccine. Report from a WHO-UNAIDS-CDC consultation, Geneva, 20-21 November 2002. Chang ML; Vitek C; Esparza J; AIDS; 2003 Oct; 17(15):W1-10. PubMed ID: 14523295 [TBL] [Abstract][Full Text] [Related]
7. Gender, age, and ethnicity in HIV vaccine-related research and clinical trials: report from a WHO-UNAIDS consultation, 26-28 August 2004. Lausanne, Switzerland. WHO-UNAIDS Expert Group AIDS; 2005 Nov; 19(17):w7-28. PubMed ID: 16260898 [TBL] [Abstract][Full Text] [Related]
8. Recombinant bacillus Calmette-Guérin as a potential vector for preventive HIV type 1 vaccines. Falk LA; Goldenthal KL; Esparza J; Aguado MT; Osmanov S; Ballou WR; Beddows S; Bhamarapravati N; Biberfeld G; Ferrari G; Hoft D; Honda M; Jackson A; Lu Y; Marchal G; McKinney J; Yamazaki S AIDS Res Hum Retroviruses; 2000 Jan; 16(2):91-8. PubMed ID: 10659047 [TBL] [Abstract][Full Text] [Related]
9. WHO, pharmaceutical industry unite against AIDS. Glob AIDSnews; 1992; (1):7. PubMed ID: 12285124 [TBL] [Abstract][Full Text] [Related]
10. Ethical considerations in international HIV vaccine trials: summary of a consultative process conducted by the Joint United Nations Programme on HIV/AIDS (UNAIDS). Guenter D; Esparza J; Macklin R J Med Ethics; 2000 Feb; 26(1):37-43. PubMed ID: 10701170 [TBL] [Abstract][Full Text] [Related]
12. European Union and EDCTP strategy in the global context: recommendations for preventive HIV/AIDS vaccines research. Lehner T; Hoelscher M; Clerici M; Gotch F; Pedneault L; Tartaglia J; Gray C; Mestecky J; Sattentau Q; van de Wijgert J; Toure C; Osmanov S; Schmidt RE; Debre P; Romaris M; Hoeveler A; Di Fabio S Vaccine; 2005 Dec; 23(48-49):5551-6. PubMed ID: 16153752 [TBL] [Abstract][Full Text] [Related]
13. Accelerating the development of an AIDS vaccine: the AIDS vaccine for Asia Network (Avan). Pitisuttithum P; Rerks-Ngarm S; Chiu J; Kim J; Benenson M; Kent SJ; Tamashiro H; Manrique A; Bernstein A; Goyal R; Ditangco RA; Cooper DA; Osmanov S; Mathieson B; Sandstrom E; Esparza J; Hoff R; Shao Y; Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1130-46. PubMed ID: 22299439 [TBL] [Abstract][Full Text] [Related]
14. An HIV vaccine: how and when? Esparza J Bull World Health Organ; 2001; 79(12):1133-7. PubMed ID: 11799445 [TBL] [Abstract][Full Text] [Related]
15. Treating people with intercurrent infection in HIV prevention trials. Report from a WHO/UNAIDS consultation, Geneva 17-18th July 2003. AIDS; 2004 Oct; 18(15):W1-12. PubMed ID: 15577617 [TBL] [Abstract][Full Text] [Related]
16. The challenges of HIV vaccine development and testing. Burgers WA; Williamson C Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):277-91. PubMed ID: 15778116 [TBL] [Abstract][Full Text] [Related]
17. Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience. Ferrantelli F; Buttò S; Cafaro A; Wahren B; Ensoli B Springer Semin Immunopathol; 2006 Nov; 28(3):289-301. PubMed ID: 16983452 [TBL] [Abstract][Full Text] [Related]
18. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa. Mamotte N; Wassenaar D; Koen J; Essack Z BMC Med Ethics; 2010 Mar; 11():3. PubMed ID: 20211030 [TBL] [Abstract][Full Text] [Related]
19. Considerations regarding efficacy endpoints in HIV vaccine trials: executive summary and recommendations of an expert consultation jointly organized by WHO, UNAIDS and ANRS in support of the Global HIV Vaccine Enterprise. Fruth U Vaccine; 2009 Mar; 27(14):1989-96. PubMed ID: 19146900 [TBL] [Abstract][Full Text] [Related]
20. Human immunodeficiency virus vaccine development in developing countries: are efficacy trials feasible? Excler JL; Beyrer C J Hum Virol; 2000; 3(4):193-214. PubMed ID: 10990167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]